Rockwell Medical (RMTI) Non Operating Investment Income (2024 - 2025)
Rockwell Medical (RMTI) posted Non Operating Investment Income of $64000.0 for Q2 2025, up 14.29% on a QoQ basis from $56000.0 in Q1 2025, and up 156.0% year-over-year from $25000.0 in Q2 2024.
Rockwell Medical (RMTI) Non Operating Investment Income (2024 - 2025) Analysis & Trends
Rockwell Medical's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $64000.0 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 27.99 Mn | 4.10 Mn | 2.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 56,000.00 |
| Mar 31, 2025 | 56,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 25,000.00 |